cerca CERCA
Sabato 23 Ottobre 2021
Aggiornato: 09:29
Temi caldi


comunicato stampa

Sinopec Puts Largest Gas Storage Cluster in North China into Operation, Providing 10 Billion Cubic Meters of Gas Storage

BEIJING, Oct. 18, 2021 /PRNewswire/ -- The Wei 11 gas storage facility built by China Petroleum & Chemical Corporation's (HKG: 0386, "Sinopec", "the Company") in its Zhongyuan Oilfield region successfully completed its first gas injection on October 18, marking the beginning of official operation of the largest underground natural gas storage cluster in north China.

comunicato stampa

SEG Solar Expanding Its Module Capacity in Cambodia

PLEASANTON, Calif., Oct. 14, 2021 /PRNewswire/ -- SEG Solar Inc. announced today that it has significantly increased the production capacity for its high-efficiency SEG 540W+ 182mm technology modules at its manufacturing facility in Cambodia to 500MW per year. This facility has been equipped with state-of-the art technology and aims to meet the growing solar market demands of North America. Production will come online in October 2021 and the first batch of solar modules are anticipated to arrive ...

comunicato stampa

Sai Life Sciences opens new Discovery Biology facility at its integrated R&D campus in Hyderabad, India

HYDERABAD, India, Aug. 18, 2021 /PRNewswire/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the opening of a new biology facility at its integrated R&D campus in Hyderabad, India. The facility marks an important milestone in the journey of positioning itself as a differentiated player in Discovery Biology.

BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study

VANCOUVER, BC and LYON, France, June 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (US OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce that its bioproduction partner Bio Elpida of Lyon, France, has initiated construction of a new Good Manufacturing Practice ("GMP") clean room facility needed for producing clinical supply of BVX-0918A, BioVaxys' ovarian cancer vaccine candidate. The design, construction and qualification of the new facility will be ded...

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal, Germany, the Pfizer China ("Pfizer") manufacturing facilities in Hangzhou, China as well as CMAB Biopharma Group ("CMAB").

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19

SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccine Contract Development and Manufacturing Organization (CDMO), today announced it achieved the weather-tight construction milestone of its vaccine manufacturing facility currently under construction in Dundalk, Ireland, while the company demonstrated extraordinary resilience despite COVID-19 challenges. The facility is expected to be operational in 2022. The modular lab was already in GMP operations ...

ora in
Prima pagina
in Evidenza